Literature DB >> 20399194

Human myeloperoxidase in innate and acquired immunity.

Juergen Arnhold1, Joerg Flemmig.   

Abstract

Polymorphonuclear leukocytes (PMNs) are important players in innate and acquired immunity. These cells accumulate at inflammatory sites and contribute to host defence, regulation of the inflammatory process, and also to tissue injury. One of the key components of PMNs is the heme-containing enzyme myeloperoxidase (MPO) that is stored in large amount in azurophilic granules of resting cells. Here we review the (patho)physiological role of MPO from the viewpoint of participation of PMNs in immune reactions. Myeloperoxidase is able to catalyse a wide range of one- and two-electron substrate oxidations. With special products, MPO contributes to apoptosis induction in PMNs and other cells, and, thus, to termination of inflammatory response. On the other hand, MPO released from necrotic cells promotes an inflammation by further recruitment of PMNs, and chemical modification of proteins and other tissue constituents. Myeloperoxidase is a fascinating, multifunctional, and challenging enzyme that has not yet revealed all its secrets. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399194     DOI: 10.1016/j.abb.2010.04.008

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  78 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

2.  Croton antisyphiliticus Mart. attenuates the inflammatory response to carrageenan-induced pleurisy in mice.

Authors:  Gustavo Oliveira Dos Reis; Geison Vicente; Francieli Kanumfre de Carvalho; Melina Heller; Gustavo Amadeu Micke; Moacir Geraldo Pizzolatti; Tânia Silvia Fröde
Journal:  Inflammopharmacology       Date:  2013-08-29       Impact factor: 4.473

3.  Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.

Authors:  Aaron Roth; Sean Ott; Kelli M Farber; Teresa A Palazzo; Wayne E Conrad; Makhluf J Haddadin; Dean J Tantillo; Carroll E Cross; Jason P Eiserich; Mark J Kurth
Journal:  Bioorg Med Chem       Date:  2014-10-02       Impact factor: 3.641

Review 4.  Exercise-induced muscle damage: mechanism, assessment and nutritional factors to accelerate recovery.

Authors:  I Markus; K Constantini; J R Hoffman; S Bartolomei; Yftach Gepner
Journal:  Eur J Appl Physiol       Date:  2021-01-08       Impact factor: 3.078

5.  Neutrophil-Derived Myeloperoxidase Facilitates Both the Induction and Elicitation Phases of Contact Hypersensitivity.

Authors:  Anna Strzepa; Cody J Gurski; Landon J Dittel; Marian Szczepanik; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

6.  Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.

Authors:  Heather L Gustafson; Song Yao; Bryan H Goldman; Kristy Lee; Catherine M Spier; Michael L LeBlanc; Lisa M Rimsza; James R Cerhan; Thomas M Habermann; Brian K Link; Matthew J Maurer; Susan L Slager; Daniel O Persky; Thomas P Miller; Richard I Fisher; Christine B Ambrosone; Margaret M Briehl
Journal:  Am J Hematol       Date:  2014-04-12       Impact factor: 10.047

7.  Dual functionality of myeloperoxidase in rotenone-exposed brain-resident immune cells.

Authors:  Chi Young Chang; Mi Jeon Song; Sae-Bom Jeon; Hee Jung Yoon; Dae Kee Lee; In-Hoo Kim; Kyungho Suk; Dong-Kug Choi; Eun Jung Park
Journal:  Am J Pathol       Date:  2011-06-23       Impact factor: 4.307

8.  Synthetic secoisolariciresinol diglucoside (LGM2605) inhibits myeloperoxidase activity in inflammatory cells.

Authors:  Om P Mishra; Anatoliy V Popov; Ralph A Pietrofesa; Eiko Nakamaru-Ogiso; Mark Andrake; Melpo Christofidou-Solomidou
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-03-07       Impact factor: 3.770

9.  MPO Promoter Polymorphism rs2333227 Enhances Malignant Phenotypes of Colorectal Cancer by Altering the Binding Affinity of AP-2α.

Authors:  Qingtao Meng; Shenshen Wu; Yajie Wang; Jin Xu; Hao Sun; Runze Lu; Na Gao; Hongbao Yang; Xiaobo Li; Boping Tang; Michael Aschner; Rui Chen
Journal:  Cancer Res       Date:  2018-03-14       Impact factor: 12.701

Review 10.  Blood flow modulation of vascular dynamics.

Authors:  Juhyun Lee; René R Sevag Packard; Tzung K Hsiai
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.